Compare Amgen, Inc. (AMGN) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Rigetti Computing Inc — how do they compare? Amgen, Inc. trades at $420.87 (market cap $229.03B), while Rigetti Computing Inc trades at $15.88 (market cap $5.25B). The key difference: Amgen, Inc. is far larger — about 43.6× Rigetti Computing Inc's market cap, and Amgen, Inc. pays a 2.38% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Amgen, Inc. for 72 Days and Rigetti Computing Inc for 33 Days on average.
| AMGN | RGTI | |
|---|---|---|
Market Cap | $229.03B | $5.25B |
Volume | 3,438,987 | 13,072,124 |
Sector | Health | Technology |
52-Week High | $444.12 | $56.34 |
52-Week Low | $290.13 | $12.90 |
Typical Hold Time | 72 Days | 33 Days |
Enterprise Value | $272.35B | $4.87B |
Dividend Yield | 2.38% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $422.07, up 0.94% on the day, near its pivot point of $421 with bullish technical signals from moving averages. The stock shows strong profitability with a net income margin of 22.95% and robust earnings beats in recent quarters. Positive Phase 3 results for dazodalibep in systemic Sjögren's disease, reported by Reuters on September 22, 2026, highlight pipeline progress.
Outlook is supported by analyst consensus leaning Buy (53.66% of ratings) and projected revenue growth to $38.1B in 2026. Risks include high debt levels and competitive pressures in biopharma. The current price exceeds the consensus target of $397.21, suggesting cautious optimism amid valuation concerns.
RGTI trades at $15.74, down 1.5% in the last 24 hours, with a bearish technical signal from moving averages and neutral oscillators. The company reported a net loss of $216.21 million in 2025, with revenue of $7.09 million, resulting in a negative net income margin of -1,787.4%. Recent news highlights quantum computing sector momentum, but RGTI faces scaling challenges with its 108-qubit system. Analyst consensus is bullish with an $21.67 price target, though cash burn remains high.
The outlook for RGTI is mixed: strong analyst support and sector tailwinds offer upside potential, but persistent losses, high valuation multiples, and execution risks in quantum commercialization pose significant threats. Investors should weigh the speculative growth prospects against the company's current financial instability and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
